COALITION FOR EPIDEMIC PREPAREDNESS INNOVATIONS
- Country
- Norway
- Type
- Beneficiary
- Grants received
- 7
Funding record
- 7 grants on record
- €276,000,000 awarded in total
- 2018–2024 span of the record
Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.
Programmes
3 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Calls from this organisation
No published calls from this organisation.
Grants received
- Development of Broadly Protective Filovirus Vaccines
- Late-stage clinical development of Chikungunya vaccines in endemic countries (CHIKV) and Controlled Human Infection Models for SARS-CoV2 and other beta coronaviruses (CHIM).
- Practical strengthening of regulatory and ethics oversight on clinical trials in West Africa using Lassa Fever vaccine development projects and increase regulatory maturity level in targeted countries
- Clinical development of Rift Valley fever vaccines in endemic regions
- PROPOSAL FOR FUNDING RESEARCH DEVELOPMENT AND MANUFACTURING OF VACCINE AGAINST COVID-19
- Developing a diverse portfolio of vaccine candidates for Rift Valley Fever, Chikungunya and Ebola
- Bringing a prophylactic Ebola vaccine to licensure
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Retrieved from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.